Intrathecal inflammatory masses: is the yearly opioid dose increase an early indicator?

Objectives:  The objective of this study is to investigate the association between intrathecal drug, flow rate, drug concentration, and drug dose with the formation of intrathecal inflammatory masses.

[1]  S. Hassenbusch,et al.  Practice choices and challenges in the current intrathecal therapy environment: an online survey. , 2009, Pain medicine.

[2]  S. Hassenbusch,et al.  Management of Intrathecal Catheter‐Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel , 2008, Neuromodulation : journal of the International Neuromodulation Society.

[3]  J. Raphael,et al.  363: First report of diamorphine associated intrathecal catheter-tip granuloma , 2007 .

[4]  J. Raphael,et al.  First report of diamorphine associated intrathecal catheter-tip granuloma: 363. , 2007 .

[5]  T. Deer,et al.  Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: a report of two cases and a review of the identification and treatment of the complication. , 2007, Pain medicine.

[6]  J. Bailes,et al.  Intrathecal morphine therapy related granulomas: two case reports. , 2006, The West Virginia medical journal.

[7]  J. Bailes,et al.  A review of intrathecal morphine therapy related granulomas , 2006, European journal of pain.

[8]  M. Cousins,et al.  Intrathecal catheter granuloma associated with isolated baclofen infusion. , 2006, Anesthesia and analgesia.

[9]  R. Rosenquist,et al.  Intrathecal catheter tip inflammatory mass: a failure of clonidine to protect. , 2005, Anesthesiology.

[10]  J. Raphael,et al.  Stability and Analgesic Efficacy of Di‐acetyl Morphine (Diamorphine) Compared with Morphine in Implanted Intrathecal Pumps In Vivo , 2004, Neuromodulation : journal of the International Neuromodulation Society.

[11]  C. Sommer,et al.  Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.

[12]  S. Hassenbusch,et al.  Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. , 2002, Pain medicine.

[13]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[14]  W. Winkelmüller,et al.  Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. , 1996, Journal of neurosurgery.

[15]  J. Blount,et al.  Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases. , 1996, Journal of neurosurgery.

[16]  D. Long,et al.  Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. , 1991, Neurosurgery.

[17]  K. Flora,et al.  Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. , 1990, American journal of hospital pharmacy.

[18]  T. Yaksh,et al.  Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. , 1981, Mayo Clinic proceedings.

[19]  Stephen P. H. Alexander,et al.  Spinal administration of the , 2012 .